Nurix Therapeutics (NRIX) EBT Margin (2019 - 2026)
Nurix Therapeutics (NRIX) reported EBT Margin of 1394.34% for Q1 2026, down 108896.0% year-over-year from N/an in Q1 2025, and down 142.02% on a QoQ basis from 576.13% in Q4 2025.
Nurix Therapeutics (NRIX) has 8 years of EBT Margin data on file, last reported at 1394.34% in Q1 2026.
- Quarterly EBT Margin fell 108896.0% year-over-year to 1394.34% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 689.37% (down 32029.0% YoY) and the FY2025 annual result came in at 314.0%, up 4036.0% from the prior year.
- EBT Margin fell to 1394.34% in Q1 2026 per NRIX's latest filing, from 576.13% in the prior quarter.
- Across five years, EBT Margin topped out at 79.14% in Q2 2023 and bottomed at 1394.34% in Q1 2026.
- The 5-year median for EBT Margin is 388.26% (2024), against an average of 466.5%.
- The widest annual swing landed in 2023, when EBT Margin soared 41196 bps; it then tumbled 108896 bps in 2026.
- Tracing NRIX's EBT Margin over 5 years: stood at 688.74% in 2022, then surged by 60 bps to 276.77% in 2023, then sank by 59 bps to 440.69% in 2024, then plunged by 31 bps to 576.13% in 2025, then plunged by 142 bps to 1394.34% in 2026.
- Per Business Quant, the three latest NRIX EBT Margin figures stand at 1394.34% (Q1 2026), 576.13% (Q4 2025), and 1094.77% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Nurix Therapeutics | 1.95 Bn | 1.41 Bn | - | -1,394.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1,394.34% |
| Nov 30, 2025 | -576.13% |
| Aug 31, 2025 | -1,094.77% |
| May 31, 2025 | -284.69% |
| Feb 28, 2025 | -305.38% |
| Nov 30, 2024 | -440.69% |
| Aug 31, 2024 | -388.26% |
| May 31, 2024 | -367.65% |
| Feb 29, 2024 | -249.79% |
| Nov 30, 2023 | -276.77% |
| Aug 31, 2023 | -200.26% |
| May 31, 2023 | -79.14% |
| Feb 28, 2023 | -321.11% |
| Nov 30, 2022 | -688.74% |
| Aug 31, 2022 | -423.58% |
| May 31, 2022 | -397.14% |
| Feb 28, 2022 | -442.09% |
| Nov 30, 2021 | -509.17% |
| Aug 31, 2021 | -282.46% |
| May 31, 2021 | -370.09% |
| Feb 28, 2021 | -483.02% |
| Nov 30, 2020 | -297.10% |
| Aug 31, 2020 | -453.29% |
| May 31, 2020 | -311.02% |
| Feb 29, 2020 | -432.26% |
| Nov 30, 2019 | -714.77% |
| Aug 31, 2019 | -22.84% |